Showing results (1321-1330 of 1,350) with videos related to

Sort By:
Pageof 135
Annals of Neurology|October 11, 2019
Spectrum of K<sub>V</sub> 2.1 Dysfunction in KCNB1-Associated Neurodevelopmental DisordersSeok Kyu Kang, Carlos G Vanoye, Sunita N Misra, et al.
Plos One|November 14, 2013
Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizesElijah R Behr, Marylyn D Ritchie, Toshihiro Tanaka, et al.
Circulation. Cardiovascular Genetics|June 12, 2014
Novel calmodulin mutations associated with congenital arrhythmia susceptibilityNaomasa Makita, Nobue Yagihara, Lia Crotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2023
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical ModelsElizabeth R Tucker, Irene Jiménez, Lindi Chen, et al.
JCO Precision Oncology|October 20, 2022
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility StudyOlivia Ruhen, Nathalie S M Lak, Janine Stutterheim, et al.
Nature Neuroscience|November 1, 2025
TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTDBrian J Joseph, Kelly A Marshall, Peter Harley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2021
Frequency and Prognostic Impact of <i>ALK</i> Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)Angela Bellini, Ulrike Pötschger, Virginie Bernard, et al.
Circulation. Cardiovascular Genetics|November 22, 2011
A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointesStefan Kääb, Dana C Crawford, Moritz F Sinner, et al.
Pageof 135